|
1
|
Sathornsumetee S, Reardon DA, Desjardins
A, Quinn JA, Vredenburgh JJ and Rich JN: Molecularly targeted
therapy for malignant glioma. Cancer. 110:13–24. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Clarke J, Butowski N and Chang S: Recent
advances in therapy for glioblastoma. Arch Neurol. 67:279–283.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Valle-Folgueral JM, Mascarenhas L, Costa
JA, Vieira F, Soares-Fernandes J, Beleza P and Alegria C: Giant
cell glioblastoma: Review of the literature and illustrated case.
Neurocirugia (Astur). 19:343–349. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Iorio MV and Croce CM: MicroRNA
dysregulation in cancer: Diagnostics, monitoring and therapeutics.
A comprehensive review. EMBO Mol Med. 4:143–159. 2012. View Article : Google Scholar
|
|
5
|
Prosdocimo G and Giacca M: Manipulating
the proliferative potential of cardiomyocytes by gene transfer.
Adult Stem Cells. Di Nardo P, Dhingra S and Singla D: 1553. Humana
Press; New York, NY; pp. 41–53. 2017, https://doi.org/10.1007/978-1-4939-6756-8_4
View Article : Google Scholar
|
|
6
|
Qiu S, Lin S, Hu D, Feng Y, Tan Y and Peng
Y: Interactions of miR-323/miR-326/miR-329 and
miR-130a/miR-155/miR-210 as prognostic indicators for clinical
outcome of glioblastoma patients. J Transl Med. 11:102013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Allen M, Bjerke M, Edlund H, Nelander S
and Westermark B: Origin of the U87MG glioma cell line: Good news
and bad news. Sci Transl Med. 8:354re32016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yabroff KR, Harlan L, Zeruto C, Abrams J
and Mann B: Patterns of care and survival for patients with
glioblastoma multiforme diagnosed during 2006. Neuro-oncol.
14:351–359. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ohgaki H, Dessen P, Jourde B, Horstmann S,
Nishikawa T, Di Patre PL, Burkhard C, Schüler D, Probst-Hensch NM,
Maiorka PC, et al: Genetic pathways to glioblastoma: A
population-based study. Cancer Res. 64:6892–6899. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Streiff MB, Ye X, Kickler TS, Desideri S,
Jani J, Fisher J and Grossman SA: A prospective multicenter study
of venous thromboembolism in patients with newly-diagnosed
high-grade glioma: Hazard rate and risk factors. J Neurooncol.
124:299–305. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang Y, Yang P and Wang XF:
Microenvironmental regulation of cancer metastasis by miRNAs.
Trends Cell Biol. 24:153–160. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fujita Y, Yoshioka Y and Ochiya T:
Extracellular vesicle transfer of cancer pathogenic components.
Cancer Sci. 107:385–390. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li BS, Zuo QF, Zhao YL, Xiao B, Zhuang Y,
Mao XH, Wu C, Yang SM, Zeng H, Zou QM, et al: MicroRNA-25 promotes
gastric cancer migration, invasion and proliferation by directly
targeting transducer of ERBB2, 1 and correlates with poor survival.
Oncogene. 34:2556–2565. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kovaleva V, Mora R, Park YJ, Plass C,
Chiramel AI, Bartenschlager R, Döhner H, Stilgenbauer S, Pscherer
A, Lichter P, et al: miRNA-130a targets ATG2B and DICER1 to inhibit
autophagy and trigger killing of chronic lymphocytic leukemia
cells. Cancer Res. 72:1763–1772. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu L, Nie J, Chen L, Dong G, Du X, Wu X,
Tang Y and Han W: The oncogenic role of microRNA-130a/301a/454 in
human colorectal cancer via targeting Smad4 expression. PLoS One.
8:e555322013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fujita Y, Kojima T, Kawakami K, Mizutani
K, Kato T, Deguchi T and Ito M: miR-130a activates apoptotic
signaling through activation of caspase-8 in taxane-resistant
prostate cancer cells. Prostate. 75:1568–1578. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pan Y, Wang R, Zhang F, Chen Y, Lv Q, Long
G and Yang K: MicroRNA-130a inhibits cell proliferation, invasion
and migration in human breast cancer by targeting the RAB5A. Int J
Clin Exp Pathol. 8:384–393. 2015.PubMed/NCBI
|
|
18
|
Ma MZ, Li CX, Zhang Y, Weng MZ, Zhang MD,
Qin YY, Gong W and Quan ZW: Long non-coding RNA HOTAIR, a c-Myc
activated driver of malignancy, negatively regulates miRNA-130a in
gallbladder cancer. Mol Cancer. 13:1562014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
He L, Wang HY, Zhang L, Huang L, Li JD,
Xiong Y, Zhang MY, Jia WH, Yun JP, Luo RZ, et al: Prognostic
significance of low DICER expression regulated by miR-130a in
cervical cancer. Cell Death Dis. 5:e12052014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang XC, Tian LL, Wu HL, Jiang XY, Du LQ,
Zhang H, Wang YY, Wu HY, Li DG, She Y, et al: Expression of
miRNA-130a in nonsmall cell lung cancer. Am J Med Sci. 340:385–388.
2010. View Article : Google Scholar : PubMed/NCBI
|
